Plus Therapeutics Inc

PSTV NASDAQ
7.30
+0.30
+4.29%
After Hours: 7.67 +0.37 +5.07% 19:20 08/21 EDT
Open
6.87
Prev Close
7.00
High
10.35
Low
6.55
Volume
1.51M
Avg Vol (3M)
327.01K
52 Week High
37.50
52 Week Low
3.800
% Turnover
340.07%
Market Cap
3.23M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Plus Therapeutics Inc PSTV stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Plus Therapeutics, Inc., formerly Cytori Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on developing treatments for patients battling cancer. The Company provides nanotechnology platform to reformulate and improve workhorse chemotherapeutics to provide benefits to patients and healthcare providers. The Company is focused on developing generic oncology drugs that address unmet medical and market needs. The Company’s lead product candidate, DocePLUS, is an albumin-stabilized PEGylated liposomal formulation of docetaxel. DocePLUS is developed for the treatment of patients with small cell lung cancer (SCLC). The Company is also developing DoxoPLUS, which is a generic PEGylated liposomal formulation of doxorubicin. DoxoPLUS is developed for the treatment of breast cancer, ovarian cancer, multiple myeloma and Kaposi’s sarcoma.
MORE >

Recently

Name
Price
%Change